Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Cancer Cell|August 4, 2009
Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signalingChristina Gewinner, Zhigang C Wang, Andrea Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 13, 2013
Synthetic lethality between CCNE1 amplification and loss of BRCA1Dariush Etemadmoghadam, Barbara A Weir, George Au-Yeung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT InhibitionGeorge Au-Yeung, Franziska Lang, Walid J Azar, et al.
Plos One|March 23, 2011
Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesisCatherine Emmanuel, Natalie Gava, Catherine Kennedy, et al.
Plos One|September 17, 2010
Copy number analysis identifies novel interactions between genomic loci in ovarian cancerKylie L Gorringe, Joshy George, Michael S Anglesio, et al.
NPJ Breast Cancer|September 1, 2021
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibitionDiar Aziz, Neil Portman, Kristine J Fernandez, et al.
Plos One|February 2, 2013
High levels of genomic aberrations in serous ovarian cancers are associated with better survivalLars O Baumbusch, Åslaug Helland, Yun Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcomeRichard W Tothill, Anna V Tinker, Joshy George, et al.
Cancer Cell|August 17, 2010
SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancerAhmed Ashour Ahmed, Zhen Lu, Nicholas B Jennings, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2013
Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancerDariush Etemadmoghadam, George Au-Yeung, Meaghan Wall, et al.
Pageof 4